BioNTech and Pfizer report initial vaccination successes – how long ago was it?
The background
On November 9, 2020, BioNTech from Mainz and the US company Pfizer reported initial data on their corona vaccine. According to a preliminary evaluation, the vaccine prevented more than 90 percent of symptomatic COVID-19 diseases compared to the placebo group. This was an important glimmer of hope during a difficult phase of the pandemic worldwide. The news made mRNA technology known to a broad audience: it provides cells with building instructions for a viral feature to which the immune system can respond. However, these were initially company information, not approval and not yet proof of lasting protection or the prevention of any infection. Further data and official audits had to follow. This was also a success for Germany as a research location.